facebook pixel
chevron_right Trending_Business
transparent
Pharma executives weigh in on possible changes under Trump
Top executives from large US drugmakers on Thursday discussed for the first time possible changes for the industry under President-elect Donald Trump, and issues that have damaged the reputation of their industry. Pharma companies are breathing a sigh of relief, but Trump could be more critical of drugmakers and their price increases than the industry expects, Allergan Inc Chief Executive Brent Saunders said on Thursday. Pharma shares jumped in the days after Trump's election as Clinton's proposed price controls fell off the table.

Want to stay updated ?

x

Download our Android app and stay updated with the latest happenings!!!


50K+ people are using this